TriVascular Technologies

^{Priced, Nasdaq: TRIV}

Markets the smallest and most versatile stent grafts for endovascular aortic repair.

Industry: Health Care

First Day Return: +14.9%

TRIV

Markets the smallest and most versatile stent grafts for endovascular aortic repair.

IPO News for TriVascular Technologies

Arterial disease device maker Avinger sets terms for $60 million IPO 01/20/15
TriVascular Technologies prices IPO at $12, below the range 04/16/14
11 US IPOs planned for the week of Apr 14 04/14/14

IPO Data
IPO Date	04/15/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$78
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.trivascular.com
Headquarters	Santa Rosa, CA, United States
Founded	1998
Employees at IPO	253

IPO News for TriVascular Technologies

Arterial disease device maker Avinger sets terms for $60 million IPO 01/20/15
TriVascular Technologies prices IPO at $12, below the range 04/16/14
11 US IPOs planned for the week of Apr 14 04/14/14

TriVascular Technologies (TRIV) Performance